Lataa...
CRISPR/Cas9 genome editing in human hematopoietic stem cells
Genome editing via homologous recombination (HR) (gene targeting) in human hematopoietic stem cells (HSCs) has the power to reveal gene–function relationships and potentially transform curative hematological gene and cell therapies. However, there are no comprehensive and reproducible protocols for...
Tallennettuna:
| Julkaisussa: | Nat Protoc |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5826598/ https://ncbi.nlm.nih.gov/pubmed/29370156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nprot.2017.143 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|